Optimizing camp and PKA sensors for cell-specific dissection of neuronal circuit in vivo
Active Cooperative Agreement Awarded
- Award ID
- UM1MH138931
- Recipient
-
Oregon Health & Science University UEI NPSNT86JKN51
- Awarding agency
-
National Institute of Mental Health
National Institutes of Health, Department of Health and Human Services
- Obligated
- $2,039,804
Award facts
- Assistance listing
- 93.242 Mental Health Research Grants
- Completion date 14% complete
- Place of performance
- Oregon, USA
Award details come from USAspending.gov.
About this award
The National Institute of Mental Health awarded a cooperative agreement totaling $2,039,804 to Oregon Health & Science University on March 2, 2026, to optimize cAMP and PKA sensors for cell-specific dissection of neuronal circuits in vivo under the Mental Health Research Grants program (CFDA 93.242). The recipient will develop fluorescence-based biosensors that enable real-time visualization of neuromodulatory signaling within specific cell types during animal behavior. The work involves structure-guided molecular dynamic analyses and high-throughput screening to identify and validate improved sensor variants, with particular emphasis on sensors compatible with fluorescence lifetime imaging for enhanced in vivo signal detection and subcellular resolution. Benchmarking will compare new variants against current best-performing sensors, with leading candidates systematically characterized and validated both in vitro and in vivo. Performance occurs in Oregon through December 31, 2030. The Leland Stanford Junior University and the University of Illinois serve as sub-recipients on this award, each conducting parallel sensor optimization and validation work under the same research objectives. The cooperative agreement structure reflects the collaborative, multi-institutional research model typical of NIMH-funded neuroscience instrumentation development, pooling expertise across academic research centers to advance foundational tools for understanding how neuromodulation controls brain circuit function and plasticity in disease and behavioral contexts.
Description
- Abstract
- Neuromodulation imposes powerful control over brain function by dynamically adjusting the gain and plasticity of brain circuits. Defects in neuromodulation are associated with many neurodegenerative and neuropsychiatric diseases. IT is increasingly appreciated that an in-depth understanding of neuromodulation would involve visualizing these events during animal behavior. Currently, in vivo interrogation of extracellular neuromodulator releases has become possible thanks to the development of neuromodulator sensors. However, neuromodulators exert their functions by regulating intracellular signaling events, such as those mediated by camp and protein kinase a (PKA), in a cell-specific manner: the same neuromodulator may trigger distinct signaling events via different receptors in different cell types. Cell-specific monitoring of neuromodulatory signaling is needed. To date, camp and PKA sensors have been developed and started to allow initial in vivo imaging applications. However, the signal remains low, hampering the simultaneous measurements of a large number of cells or the visualization events confined in subcellular compartments. Here, we propose to optimize a fret-based multi-fluorophore sensor for PKA activity and a single-fluorophore sensor for camp that provide complementary information. We will prioritize developing sensors compatible with fluorescence lifetime imaging, which is increasingly recognized to provide unparalleled advantages for imaging signaling events in vivo. We will employ structure-guided molecular dynamic analyses to identify critical positions within each sensor and use a modern high-throughput platform to screen for effective variants. We will benchmark the new variants against previous sensors. Leading candidates will be systematically characterized, benchmarked against current best sensors, and validated in vitro and in vivo. This proposal harnesses the complementary expertise from individual team members, including experimental structural biology, molecular dynamics, sensor development and characterization, and in vivo two-photon lifetime imaging. Successful tools will be used to generate adeno-associated viruses (AAVS) and other cell type-specific expression vehicles for easy use and dissemination to the broader research community. If successful, our proposed study will propel the ability to visualize camp/PKA signaling activities in vivo with previously unattained spatial and temporal resolution for mechanistic studies of brain function and dysfunction. This ability to monitor neuromodulatory signaling will complement the measurements of extracellular neuromodulators and neuronal electric activities to enhance our understanding of brain function underlying animal behavior.
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The Leland Stanford Junior University | $195,784 | |
| University Of Illinois | $294,558 |
Quick answers
Who received award UM1MH138931?
UM1MH138931 was awarded to Oregon Health & Science University by National Institute of Mental Health (National Institutes of Health) on March 2, 2026.
How much is award UM1MH138931 worth?
$2,039,804 has been obligated on UM1MH138931.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award